{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:33Z","timestamp":1792782753121,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS055746, R21 NS089516"],"award-info":[{"award-number":["R01 NS055746, R21 NS089516"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Michigan Protein Folding Disease Initiative","id":[{"id":"https:\/\/ror.org\/00jmfr291","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00018-016-2275-1","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T23:20:09Z","timestamp":1463440809000},"page":"3991-3999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Polyglutamine androgen receptor-mediated neuromuscular disease"],"prefix":"10.1007","volume":"73","author":[{"given":"Elisa","family":"Giorgetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"2275_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621","journal-title":"Annu Rev Neurosci"},{"issue":"6330","key":"2275_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR et al (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352(6330):77\u201379","journal-title":"Nature"},{"key":"2275_CR3","first-page":"3","volume":"16","author":"H Kawahara","year":"1897","unstructured":"Kawahara H (1897) A family of progressive bulbar palsy. Aichi Med School J 16:3\u20134","journal-title":"Aichi Med School J"},{"issue":"7","key":"2275_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"W Kennedy","year":"1968","unstructured":"Kennedy W, Alter M, Sung J (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. Neurology 18(7):671\u2013680","journal-title":"Neurology"},{"issue":"11","key":"2275_CR5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/jnnp.45.11.1012","volume":"45","author":"AE Harding","year":"1982","unstructured":"Harding AE et al (1982) X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 45(11):1012\u20131019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2275_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt BJ et al (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59(5):770\u2013772","journal-title":"Neurology"},{"issue":"1\u20132","key":"2275_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0022-510X(93)90157-T","volume":"117","author":"G Sobue","year":"1993","unstructured":"Sobue G et al (1993) Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J Neurol Sci 117(1\u20132):74\u201378","journal-title":"J Neurol Sci"},{"issue":"2\u20133","key":"2275_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-510X(88)90240-7","volume":"87","author":"T Nagashima","year":"1988","unstructured":"Nagashima T et al (1988) Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy\u2013Alter\u2013Sung syndrome). Autopsy case report of two brothers. J Neurol Sci 87(2\u20133):141\u2013152","journal-title":"J Neurol Sci"},{"issue":"4","key":"2275_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00131402-200306000-00001","volume":"4","author":"F Battaglia","year":"2003","unstructured":"Battaglia F et al (2003) Kennedy\u2019s disease initially manifesting as an endocrine disorder. J Clin Neuromuscul Dis 4(4):165\u2013167","journal-title":"J Clin Neuromuscul Dis"},{"issue":"10","key":"2275_CR10","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI28773","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu Z et al (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116(10):2663\u20132672","journal-title":"J Clin Invest"},{"issue":"20","key":"2275_CR11","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES et al (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24(20):4778\u20134786","journal-title":"J Neurosci"},{"issue":"5","key":"2275_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno M et al (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35(5):843\u2013854","journal-title":"Neuron"},{"issue":"12","key":"2275_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1212\/WNL.36.12.1595","volume":"36","author":"K Fischbeck","year":"1986","unstructured":"Fischbeck K et al (1986) Localization of the gene for X-linked spinal muscular atrophy. Neurology 36(12):1595\u20131598","journal-title":"Neurology"},{"key":"2275_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2004.03.001","volume":"25","author":"A Poletti","year":"2004","unstructured":"Poletti A (2004) The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front Neuroendocrinol 25:1\u201326","journal-title":"Front Neuroendocrinol"},{"key":"2275_CR15","first-page":"255","volume":"81","author":"P Clark","year":"2003","unstructured":"Clark P, Irvine R, Coetzee G (2003) The androgen receptor CAG repeat and prostate cancer risk. Methods Mol Med 81:255\u2013266","journal-title":"Methods Mol Med"},{"issue":"3","key":"2275_CR16","doi-asserted-by":"publisher","first-page":"E393","DOI":"10.1210\/jc.2011-2439","volume":"97","author":"C Davis-Dao","year":"2012","unstructured":"Davis-Dao C et al (2012) Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab 97(3):E393\u2013E399","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20135","key":"2275_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsbmb.2007.09.016","volume":"108","author":"I Palazzolo","year":"2008","unstructured":"Palazzolo I et al (2008) The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol 108(3\u20135):245\u2013253","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2275_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1615\/CritRevEukarGeneExpr.v5.i2.10","volume":"5","author":"C Chang","year":"1995","unstructured":"Chang C et al (1995) Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr 5(2):97\u2013125","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"2275_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/0008-5472.CAN-05-2389","volume":"66","author":"L Callewaert","year":"2006","unstructured":"Callewaert L, Van Tilborgh N, Claessens F (2006) Interplay between two hormone-independent activation domains in the androgen receptor. Cancer Res 66(1):543\u2013553","journal-title":"Cancer Res"},{"issue":"1","key":"2275_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"EM Tan","year":"2015","unstructured":"Tan EM et al (2015) Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 36(1):3\u201323","journal-title":"Acta Pharmacol Sin"},{"issue":"51","key":"2275_CR21","doi-asserted-by":"publisher","first-page":"49230","DOI":"10.1074\/jbc.M209322200","volume":"277","author":"V Christiaens","year":"2002","unstructured":"Christiaens V et al (2002) Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control. J Biol Chem 277(51):49230\u201349237","journal-title":"J Biol Chem"},{"issue":"1","key":"2275_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0006-291X(03)00902-1","volume":"306","author":"L Callewaert","year":"2003","unstructured":"Callewaert L et al (2003) Implications of a polyglutamine tract in the function of the human androgen receptor. Biochem Biophys Res Commun 306(1):46\u201352","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2275_CR23","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.1128\/MCB.19.12.8383","volume":"19","author":"CL Bevan","year":"1999","unstructured":"Bevan CL et al (1999) The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19(12):8383\u20138392","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2275_CR24","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell A et al (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9(4):2197\u20132202","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2275_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/hmg\/8.5.731","volume":"8","author":"DL Stenoien","year":"1999","unstructured":"Stenoien DL et al (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8(5):731\u2013741","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2275_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","volume":"21","author":"M Rechsteiner","year":"1996","unstructured":"Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21(6):267\u2013271","journal-title":"Trends Biochem Sci"},{"issue":"24","key":"2275_CR27","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1128\/MCB.00647-13","volume":"33","author":"L Ni","year":"2013","unstructured":"Ni L et al (2013) Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor. Mol Cell Biol 33(24):4766\u20134778","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2275_CR28","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00018-010-0302-1","volume":"67","author":"TM Tanner","year":"2010","unstructured":"Tanner TM et al (2010) A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell Mol Life Sci 67(11):1919\u20131927","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"2275_CR29","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1158\/0008-5472.CAN-06-1701","volume":"67","author":"A Haelens","year":"2007","unstructured":"Haelens A et al (2007) The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res 67(9):4514\u20134523","journal-title":"Cancer Res"},{"issue":"1","key":"2275_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2012.02.019","volume":"358","author":"L Clinckemalie","year":"2012","unstructured":"Clinckemalie L et al (2012) The hinge region in androgen receptor control. Mol Cell Endocrinol 358(1):1\u20138","journal-title":"Mol Cell Endocrinol"},{"issue":"27","key":"2275_CR31","doi-asserted-by":"publisher","first-page":"20853","DOI":"10.1074\/jbc.M000660200","volume":"275","author":"M Fu","year":"2000","unstructured":"Fu M et al (2000) p300 and p300\/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 275(27):20853\u201320860","journal-title":"J Biol Chem"},{"issue":"3","key":"2275_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","volume":"99","author":"M Katsuno","year":"2012","unstructured":"Katsuno M et al (2012) Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog Neurobiol 99(3):246\u2013256","journal-title":"Prog Neurobiol"},{"issue":"52","key":"2275_CR33","doi-asserted-by":"publisher","first-page":"37219","DOI":"10.1074\/jbc.274.52.37219","volume":"274","author":"B He","year":"1999","unstructured":"He B et al (1999) Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem 274(52):37219\u201337225","journal-title":"J Biol Chem"},{"issue":"43","key":"2275_CR34","doi-asserted-by":"publisher","first-page":"41998","DOI":"10.1074\/jbc.M302460200","volume":"278","author":"AJ Saporita","year":"2003","unstructured":"Saporita AJ et al (2003) Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem 278(43):41998\u201342005","journal-title":"J Biol Chem"},{"issue":"6","key":"2275_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neuron.2010.09.012","volume":"67","author":"IH Kratter","year":"2010","unstructured":"Kratter IH, Finkbeiner S (2010) PolyQ disease: too many Qs, too much function? Neuron 67(6):897\u2013899","journal-title":"Neuron"},{"issue":"3","key":"2275_CR36","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","volume":"7","author":"AP Lieberman","year":"2014","unstructured":"Lieberman AP et al (2014) Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 7(3):774\u2013784","journal-title":"Cell Rep"},{"issue":"2","key":"2275_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","volume":"82","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ et al (2014) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82(2):295\u2013307","journal-title":"Neuron"},{"issue":"3","key":"2275_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H Adachi","year":"2005","unstructured":"Adachi H et al (2005) Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128(3):659\u2013670","journal-title":"Brain"},{"issue":"1","key":"2275_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2353\/ajpath.2006.050619","volume":"168","author":"Z Yu","year":"2006","unstructured":"Yu Z et al (2006) Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol 168(1):195\u2013204","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"2275_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1385\/JMN:23:1-2:069","volume":"23","author":"A Wyttenbach","year":"2004","unstructured":"Wyttenbach A (2004) Role of heat shock proteins during polyglutamine neurodegeneration. J Mol Neurosci 23(1\u20132):69\u201395","journal-title":"J Mol Neurosci"},{"issue":"6","key":"2275_CR41","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.bbadis.2012.02.006","volume":"1822","author":"T Jochum","year":"2012","unstructured":"Jochum T et al (2012) Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures. Biochim Biophys Acta 1822(6):1070\u20131078","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2275_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/hmg\/ddg074","volume":"12","author":"JP Taylor","year":"2003","unstructured":"Taylor JP et al (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 12(7):749\u2013757","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2275_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11\u201322","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2275_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0002-9440(10)65612-X","volume":"153","author":"M Li","year":"1998","unstructured":"Li M et al (1998) Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol 153(3):695\u2013701","journal-title":"Am J Pathol"},{"issue":"2","key":"2275_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li M et al (1998) Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 44(2):249\u2013254","journal-title":"Ann Neurol"},{"issue":"12","key":"2275_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nchembio.694","volume":"7","author":"J Miller","year":"2011","unstructured":"Miller J et al (2011) Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol 7(12):925\u2013934","journal-title":"Nat Chem Biol"},{"key":"2275_CR47","doi-asserted-by":"crossref","unstructured":"Montie HL et al (2009) Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 18(11)","DOI":"10.1093\/hmg\/ddp115"},{"issue":"5","key":"2275_CR48","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K-I Takeyama","year":"2002","unstructured":"Takeyama K-I et al (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35(5):855\u2013864","journal-title":"Neuron"},{"key":"2275_CR49","doi-asserted-by":"crossref","unstructured":"Pratt WB, Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery. Exp Biol Med (Maywood)","DOI":"10.1177\/153537020322800201"},{"key":"2275_CR50","doi-asserted-by":"crossref","unstructured":"Pratt WB et al (2014) A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to neuroprotective treatment of protein folding diseases. Exp Biol Med 1\u20139","DOI":"10.1177\/1535370214539444"},{"issue":"3","key":"2275_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1258\/ebm.2009.009250","volume":"235","author":"WB Pratt","year":"2010","unstructured":"Pratt WB et al (2010) Proposal for a role of the Hsp90\/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med (Maywood) 235(3):278\u2013288","journal-title":"Exp Biol Med (Maywood)"},{"key":"2275_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010814-124332","volume":"55","author":"WB Pratt","year":"2014","unstructured":"Pratt WB et al (2014) Targeting Hsp90\/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annu Rev Pharmacol Toxicol 55:353\u2013371","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"34","key":"2275_CR53","doi-asserted-by":"publisher","first-page":"22885","DOI":"10.1074\/jbc.R800023200","volume":"283","author":"WB Pratt","year":"2008","unstructured":"Pratt WB, Morishima Y, Osawa Y (2008) The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts. J Biol Chem 283(34):22885\u201322889","journal-title":"J Biol Chem"},{"issue":"19","key":"2275_CR54","first-page":"5115","volume":"27","author":"H Adachi","year":"2007","unstructured":"Adachi H et al (2007) CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. Neurobiol Dis 27(19):5115\u20135126","journal-title":"Neurobiol Dis"},{"key":"2275_CR55","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M Waza","year":"2005","unstructured":"Waza M et al (2005) 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 11:1088\u20131095","journal-title":"Nat Med"},{"key":"2275_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio.1140","volume":"9","author":"AM Wang","year":"2013","unstructured":"Wang AM et al (2013) Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol 9:112\u2013118","journal-title":"Nat Chem Biol"},{"issue":"8","key":"2275_CR57","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1242\/jcs.096792","volume":"125","author":"ME Van Royen","year":"2012","unstructured":"Van Royen ME et al (2012) Stepwise androgen receptor dimerization. J Cell Sci 125(8):1970\u20131979","journal-title":"J Cell Sci"},{"issue":"6","key":"2275_CR58","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky NB et al (2010) Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67(6):936\u2013952","journal-title":"Neuron"},{"issue":"46","key":"2275_CR59","doi-asserted-by":"publisher","first-page":"35567","DOI":"10.1074\/jbc.M110.146845","volume":"285","author":"CR Orr","year":"2010","unstructured":"Orr CR et al (2010) An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem 285(46):35567\u201335577","journal-title":"J Biol Chem"},{"issue":"10","key":"2275_CR60","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.celrep.2015.11.019","volume":"13","author":"L Zboray","year":"2015","unstructured":"Zboray L et al (2015) Preventing the androgen receptor N\/C interaction delays disease onset in a mouse model of SBMA. Cell Rep 13(10):2312\u20132323","journal-title":"Cell Rep"},{"issue":"17","key":"2275_CR61","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","volume":"11","author":"AP Lieberman","year":"2002","unstructured":"Lieberman AP et al (2002) Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 11(17):1967\u20131976","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2275_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1677\/erc.0.0110117","volume":"11","author":"SM Powell","year":"2004","unstructured":"Powell SM et al (2004) Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. Endocr Relat Cancer 11(1):117\u2013130","journal-title":"Endocr Relat Cancer"},{"issue":"16","key":"2275_CR63","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1523\/JNEUROSCI.0388-10.2010","volume":"30","author":"M Katsuno","year":"2010","unstructured":"Katsuno M et al (2010) Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J Neurosci 30(16):5702\u20135712","journal-title":"J Neurosci"},{"issue":"5","key":"2275_CR64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","volume":"41","author":"B Sopher","year":"2004","unstructured":"Sopher B et al (2004) Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 41(5):687\u2013699","journal-title":"Neuron"},{"issue":"11","key":"2275_CR65","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","volume":"13","author":"M Minamiyama","year":"2004","unstructured":"Minamiyama M et al (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 13(11):1183\u20131192","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2275_CR66","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nrn1989","volume":"7","author":"R Butler","year":"2006","unstructured":"Butler R, Bates GP (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 7(10):784\u2013796","journal-title":"Nat Rev Neurosci"},{"issue":"26","key":"2275_CR67","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1073\/pnas.261400698","volume":"98","author":"A McCampbell","year":"2001","unstructured":"McCampbell A et al (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA 98(26):15179\u201315184","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6857","key":"2275_CR68","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739\u2013743","journal-title":"Nature"},{"issue":"13","key":"2275_CR69","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","volume":"16","author":"I Palazzolo","year":"2007","unstructured":"Palazzolo I et al (2007) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 16(13):1593\u20131603","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2275_CR70","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I et al (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63(3):316\u2013328","journal-title":"Neuron"},{"issue":"48","key":"2275_CR71","first-page":"17425","volume":"31","author":"HL Montie","year":"2011","unstructured":"Montie HL, Pestell RG, Merry DE (2011) SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. Neurobiol Dis 31(48):17425\u201317436","journal-title":"Neurobiol Dis"},{"issue":"32","key":"2275_CR72","doi-asserted-by":"publisher","first-page":"21296","DOI":"10.1074\/jbc.M109.011494","volume":"284","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S et al (2009) Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem 284(32):21296\u201321306","journal-title":"J Biol Chem"},{"key":"2275_CR73","unstructured":"Chua JP et al (2014) Disrupting SUMOylation potentiates transactivation function and ameliorates polyglutamine AR-mediated disease. J Clin Invest"},{"key":"2275_CR74","first-page":"209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue G et al (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112:209\u2013232","journal-title":"A clinicopathological study. Brain"},{"issue":"1","key":"2275_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/brain\/awm289","volume":"131","author":"K Suzuki","year":"2008","unstructured":"Suzuki K et al (2008) CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 131(1):229\u2013239","journal-title":"Brain"},{"issue":"1","key":"2275_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2006.01.021","volume":"200","author":"M Katsuno","year":"2006","unstructured":"Katsuno M et al (2006) Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 200(1):8\u201318","journal-title":"Exp Neurol"},{"issue":"5","key":"2275_CR77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jnnp.2009.190462","volume":"81","author":"K Suzuki","year":"2010","unstructured":"Suzuki K et al (2010) The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. J Neurol Neurosurg Psychiatry 81(5):567\u2013571","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2275_CR78","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/brain\/awl096","volume":"129","author":"N Atsuta","year":"2006","unstructured":"Atsuta N et al (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129(6):1446\u20131455","journal-title":"Brain"},{"issue":"12","key":"2275_CR79","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awp258","volume":"132","author":"LE Rhodes","year":"2009","unstructured":"Rhodes LE et al (2009) Clinical features of spinal and bulbar muscular atrophy. Brain 132(12):3242\u20133251","journal-title":"Brain"},{"issue":"1\u20132","key":"2275_CR80","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","volume":"264","author":"G Sorar\u00f9","year":"2008","unstructured":"Sorar\u00f9 G et al (2008) Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci 264(1\u20132):100\u2013105","journal-title":"J Neurol Sci"},{"issue":"5","key":"2275_CR81","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/hmg\/ddt527","volume":"23","author":"JP Chua","year":"2014","unstructured":"Chua JP et al (2014) Transcriptional activation of TFEB\/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet 23(5):1376\u20131386","journal-title":"Hum Mol Genet"},{"key":"2275_CR82","doi-asserted-by":"crossref","unstructured":"Yu Z et al (2011) Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice. PLoS Genet 7(10)","DOI":"10.1371\/journal.pgen.1002321"},{"key":"2275_CR83","doi-asserted-by":"crossref","unstructured":"Rusmini P et al (2015) Aberrant autophagic response in the muscle of a knock-in mouse model of spinal and bulbar muscular atrophy. Sci Rep 5(15174)","DOI":"10.1038\/srep15174"},{"issue":"46","key":"2275_CR84","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1073\/pnas.0705501104","volume":"104","author":"DA Monks","year":"2007","unstructured":"Monks DA et al (2007) Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci USA 104(46):18259\u201318264","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2275_CR85","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","volume":"18","author":"C Rinaldi","year":"2012","unstructured":"Rinaldi C et al (2012) Insulin like growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med 18(1):1261\u20131268","journal-title":"Mol Med"},{"key":"2275_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00401-013-1122-9","volume":"126","author":"A Malena","year":"2013","unstructured":"Malena A et al (2013) Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol 126:109\u2013121","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2275_CR87","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1083\/jcb.123.2.455","volume":"123","author":"H Funakoshi","year":"1993","unstructured":"Funakoshi H et al (1993) Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 123(2):455\u2013465","journal-title":"J Cell Biol"},{"issue":"16","key":"2275_CR88","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1523\/JNEUROSCI.3599-14.2015","volume":"35","author":"F Ramzan","year":"2015","unstructured":"Ramzan F et al (2015) Distinct etiological roles for myocytes and motor neurons in a mouse model of Kennedy\u2019s disease\/spinobulbar muscular atrophy. J Neurosci 35(16):6444\u20136451","journal-title":"J Neurosci"},{"issue":"21","key":"2275_CR89","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","volume":"24","author":"K Sahashi","year":"2015","unstructured":"Sahashi K et al (2015) Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 24(21):5985\u20135994","journal-title":"Hum Mol Genet"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2275-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2275-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:08:31Z","timestamp":1589641711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2275-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":89,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2275"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2275-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"assertion":[{"value":"30 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}